Andere talen CareDx, Inc

Aandelen

CDNA

US14167L1035

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
7,98 ^USD	-3,04%		-3,62%	-33,50%

16/04	CareDx, Inc benoemt John W. Hanna tot Chief Executive Officer	CI
16/04	CareDx, Inc benoemt John W. Hanna tot President en lid van de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	19/04
CareDx Appoints John Hanna as CEO, President	16/04
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer	16/04
CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	16/04
CareDx, Inc Appoints John W. Hanna as President and Member of the Board of Directors	16/04
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	09/04
CareDx et ses collaborateurs présentent les dernières avancées dans le domaine cardio-thoracique lors de la réunion 2024 de la Société internationale de transplantation cardiaque et pulmonaire	09/04
CareDx und Mitarbeiter präsentieren neueste Herz-Thorax-Fortschritte im Rahmen des 2024 International Society for Heart and Lung Transplantation Meeting	09/04
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting	09/04
CareDx Appoints Bryan Riggsbee to Its Board of Directors	11/03
CareDx, Inc Appoints Bryan Riggsbee to Its Board of Directors	11/03
CareDx : Appoints Bryan Riggsbee to Its Board of Directors - Form 8-K	11/03
CareDx : Corporate Presentation February 2024	01/03
CareDx: Q4 Earnings Snapshot	28/02
Earnings Flash (CDNA) CAREDX Reports Q4 Revenue $65.6M, vs. Street Est of $64.1M	28/02
CareDx, Inc Provides Revenue Guidance for the Full Year of 2024	28/02
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results	28/02
CareDx, Inc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference	27/02
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results	21/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CareDx, Inc

Aandelen

CDNA

US14167L1035

Andere talen

Filters